Sign Up to like & get
recommendations!
0
Published in 2020 at "Heart rhythm"
DOI: 10.1016/j.hrthm.2020.10.022
Abstract: BACKGROUND Acquired long QT syndrome (aLQTS) is often associated with poor clinical outcomes. OBJECTIVE The present study examined the important predictors for all-cause mortality of aLQTS patients by applying both random survival forest (RSF) and…
read more here.
Keywords:
long syndrome;
cause mortality;
random survival;
mortality ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Renal Failure"
DOI: 10.1080/0886022x.2019.1707098
Abstract: Abstract Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in chronic kidney disease (CKD) patients. QT interval prolongation is a congenital or acquired condition that is associated with an increased risk of…
read more here.
Keywords:
chronic kidney;
long syndrome;
acquired long;
disease ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Cardiovascular Research"
DOI: 10.1093/cvr/cvac103
Abstract: Abstract Aims Long QT syndrome (LQTS) carries a risk of life-threatening polymorphic ventricular tachycardia (Torsades de Pointes, TdP) and is a major cause of premature sudden cardiac death. TdP is induced by R-on-T premature ventricular…
read more here.
Keywords:
initiation ventricular;
arrhythmia acquired;
long syndrome;
acquired long ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "PLoS ONE"
DOI: 10.1371/journal.pone.0208321
Abstract: Increased proinflammatory interleukin-6 (IL-6) levels are associated with acquired long QT-syndrome (LQTS) in patients with systemic inflammation, leading to higher risks for life-threatening polymorphic ventricular tachycardia such as Torsades de Pointes. However, the functional and…
read more here.
Keywords:
herg;
acquired long;
systemic inflammation;
interleukin inhibition ... See more keywords